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Purpose: To compare differences in visual acuity, contrast sensitivity, complications, and 
higher-order ocular aberrations (HOAs) in eyes with stable myopia undergoing either photo-
refractive keratectomy (PRK) or thin-flap laser in situ keratomileusis (LASIK) (intended flap 
thickness of 90 µm) using the VISX Star S4 CustomVue excimer laser and the IntraLase FS60 
femtosecond laser at 1, 3, and 6 months postoperatively.
Methods: In this prospective, masked, and randomized pilot study, refractive surgery was 
performed contralaterally on 52 eyes: 26 with PRK and 26 with thin-flap LASIK. Primary 
outcome measures were uncorrected distance visual acuity (UDVA), corrected distance visual 
acuity (CDVA), contrast sensitivity, and complications.
Results: At 6 months, mean values for UDVA (logMAR) were −0.043 ± 0.668 and   
−0.061 ± 0.099 in the PRK and thin-flap LASIK groups, respectively (n = 25, P = 0.466). 
UDVA of 20/20 or better was achieved in 96% of eyes undergoing PRK and 92% of eyes 
undergoing thin-flap LASIK, whereas 20/15 vision or better was achieved in 73% of eyes 
undergoing PRK and 72% of eyes undergoing thin-flap LASIK (P . 0.600). Significant 
differences were not found between treatment groups in contrast sensitivity (P $ 0.156) or 
CDVA (P = 0.800) at postoperative 6 months. Types of complications differed between groups, 
notably 35% of eyes in the thin-flap LASIK group experiencing complications, including 
microstriae and 2 flap tears.
Conclusion: Under well-controlled surgical conditions, PRK and thin-flap LASIK refractive 
surgeries achieve similar results in visual acuity, contrast sensitivity, and induction of HOAs, 
with differences in experienced complications.
Keywords: photorefractive keratectomy, thin-flap LASIK, visual function
Introduction
Refractive surgery is one of the most commonly performed elective procedures 
and will likely maintain its popularity as ablation techniques become more refined 
and understanding of corneal wound healing improves. Two of the most common 
  methods of refractive surgery are photorefractive keratectomy (PRK) and laser in situ 
  keratomileusis (LASIK). The rapid improvement in vision and lack of postoperative 
pain associated with LASIK has made this the preferred option with patients compared 
with PRK, which has greater postoperative discomfort and prolonged recovery of 
visual acuity.1 Recently, there has been renewed interest in PRK because of increasing 
concerns of complications associated with LASIK flap creation, including dry eye, 
corneal ectasia, and flap tears.2–5
Thin-flap LASIK attempts to gain benefits of both techniques by creating a flap 
of between 80 and 90 µm.6–8 Use of a thinner flap results in a more biomechanically Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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stable cornea and decreases incidence of ectasia given the 
thicker residual stroma.3,9 Cutting a thinner LASIK flap is less 
invasive to the nerves within the corneal stroma, decreasing 
the severity and duration of dry eye, possibly by preserving 
corneal sensation and blinking rate.10–14 Flap creation avoids 
corneal epithelium removal, allowing reduced healing time 
and less haze and scarring.15 The present contralateral study 
compares the outcomes of eyes that have undergone PRK 
or thin-flap LASIK using the VISX STAR S4 excimer laser 
(VISX Incorporated, Santa Clara, CA), with flaps created 
with intended thicknesses of 90 µm using the IntraLase 
FS60 femtosecond laser (Abbott Medical Optics [AMO], 
Santa Ana, CA).
Methods
Data from myopic eyes were analyzed, with or without astig-
matism, in which the dominant eye was randomized (Research 
Randomizer software – Urbaniak, www.randomizer.org) to 
PRK or thin-flap LASIK (90 µm flap) and the nondominant 
eye underwent the alternative treatment. All PRK and thin-
flap LASIK treatments were performed using the VISX Star 
S4 CustomVue laser at the John A. Moran Eye Center, Salt 
Lake City, Utah, between February 2008 and July 2009. All 
surgeries were overseen by two surgeons (M.M., M.D.M.). 
The research protocol was approved by the University of 
Utah Hospital Institutional Review Board.
All patients included in this study met the US Food 
and Drug Administration guidelines for VISX CustomVue 
LASIK. Mean age of patient, 13 men and 13 women, was 
30.8 years (range: 23–46). Twenty-six patients (52 eyes) 
with stable myopia (1.5–8.5 diopters [D]) and astigmatism 
(0.242–3.11 D) were enrolled in the study. Eleven patients 
excluded from this study had clinically significant lens 
  opacities,   previous corneal or intraocular surgery, kerato-
conus, unstable refraction, autoimmune disease, immuno-
suppressive therapy, or were pregnant or breastfeeding. 
Correction was made for distance and patients desiring 
monovision correction were excluded. Contact lenses were 
discontinued 2 weeks prior to screening for soft contact lens 
wearers and 6 weeks prior to screening for rigid gas perme-
able lens   wearers. All patients had a preoperative examina-
tion including assessment of uncorrected distance visual 
acuity (UDVA), corrected distance visual acuity (CDVA), 
tonometry, slitlamp examination of the anterior segment, 
and dilated fundus examination. Manifest and cycloplegic 
refractions were repeated on 2 separate visits to ensure reli-
ability and stability. Corneal topography and thickness were 
measured using the Orbscan II v.3.0 (Bausch and Lomb, 
Rochester, NY). All eyes received 5 preoperative wavefront 
analyses with the VISX CustomVue WaveScan aberrometer 
v.3.62 (Fourier) (AMO), without pharmacologic intervention, 
under mesopic conditions, with a minimum pupil diameter 
of 6.0 mm.
The contralateral study design was made so that each eye 
could act as a control for the fellow eye in each patient, allowing 
for study groups to be well matched. There were no violations 
in the randomization; all patients were analyzed as originally 
assigned. The randomization protocol was generated before the 
trial and known only to the study coordinator. In all patients, the 
emmetropic correction target was based on manifest refraction 
and wavefront analysis. All flaps were created with the IntraL-
ase FS60 femtosecond laser at 60 kHz in a raster pattern with 
bed energy of 1.15 µJ, side-cut energy of 2.00 µJ, and pocket 
enabled. The flaps were created with an intended thickness of 
Table 1 Preoperative group comparisons
Parameter PRK  
(n = 25)
Thin-flap LASIK  
(n = 25)
P valuea
Mean UDVA (logMAr) ± sD 1.286 ± 0.312 1.269 ± 1.178 0.866
Mean UDVA (20/x) ± sD 478.26 ± 283.10 480.65 ± 301.20 0.855
CDVA (logMAr) ± sD −0.0211 ± 0.0564 −0.0211 ± 0.0564 1.00
(−0.125 to 0.097) (−0.125 to 0.097)
CDVA (20/x) ± sD 19.2 ± 2.4 
(15 to 25)
19.2 ± 2.4 
(15 to 25)
1.00
sphere (D) ± sD −4.67 ± 1.95 
(−8.50 to −1.50)
−4.74 ± 2.07 
(−7.75 to −0.60)
0.732
Cylinder (D) ± sD 0.86 ± 0.72 
(0.00 to 2.25)
0.81 ± 0.70 
(0.00 to 2.50)
0.805
Central corneal thickness (µm) ± sD 556 ± 29 
(502 to 596)
554 ± 27 
(503 to 598)
0.719
Notes: Values represented as mean ± standard deviation (range); aindependent samples t-test.
Abbreviations: UDVA, uncorrected distance visual acuity; CDVA, corrected distance visual acuity.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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90 µm, diameter of 8.4 to 9.0 mm, superior hinge angle of 55°, 
and a side-cut angle of 70°. Intraoperative pachymetry or optical 
coherence tomography were not performed to evaluate actual 
flap thicknesses. If the 8.0 mm maximum intended ablation 
diameter exceeded the flap   diameter, the hinge and flap were 
shielded during ablation.
Postoperatively, each eye undergoing thin-flap LASIK 
received 1 drop of gatifloxacin 0.3% (Zymar; Allergan 
Inc, Irvine, CA), prednisolone acetate 1% (Pred Forte, 
Allergan Inc), ketorolac tromethamine 0.4% (Acular LS, 
Allergan Inc.), and a bandage soft contact lens (Softlens 
Plano T, Bausch and Lomb, Rochester, NY). The predni-
solone acetate was continued hourly during the first preop-
erative day and 4 times daily for an additional 6 days. The 
gatifloxacin was continued 4 times daily for 1 week.
In eyes undergoing PRK all eyes had their corneas cooled 
with 15 mL of BSS (2.8–3.9°C) immediately following 
  ablation. This was followed by 1 drop of a gatifloxacin 0.3% 
(Zymar), prednisolone acetate 1% (Pred Forte), ketorolac 
tromethamine 0.4% (Acular LS) and a bandage soft con-
tact lens (Softlens Plano T). Ketorolac tromethamine was 
continued 4 times a day for 3 days and then discontinued. 
Gatifloxacin and prednisolone acetate were continued 4 
times a day for 1 week with a subsequent steroid taper over 
2 to 3 months per surgeon preference. Mitomycin C was not 
administered to any patient in the study at any time. Both 
bandage soft contact lenses were removed simultaneously 
once re-epithelialization was complete, typically on postop-
erative days 3 to 5.
Patients were seen 1 day, 1 week, 1 month ± 10 days, 
3 months ± 14 days, and 6 months ± 14 days. At all   follow-up 
examinations, UDVA and CDVA were tested using a 
  standard Snellen eye chart. Visual acuity was recorded in 
both Snellen notation and logarithm of the minimum angle 
of resolution (logMAR) format. Contrast sensitivity was 
measured in controlled mesopic conditions at 3, 6, 12, and 
18 cycles per degree (cpd) using the Vectorvision CSV-
1000E chart (Vectorvision, Greenville, OH). Higher-order 
  aberrations (HOAs), including coma Z(3,1), trefoil Z(3,3), 
and spherical aberration Z(4,0), were measured using 
the CustomVue WaveScan at a mean diameter of 6 mm. 
  Undilated scans of both eyes were taken preoperatively and 
1, 3, and 6 months postoperatively.
Primary outcome measures were UDVA, CDVA, con-
trast sensitivity, and complications. HOAs were measured 
and trended within groups as secondary measures. After the 
study was completed, the results were compiled and the data 
unmasked for statistical analysis. Refractive error, visual Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Table 3 Efficacy, predictability, and safety comparisons of PRK and thin-flap LASIK
Parameter Postoperative month 1 Postoperative month 3 Postoperative month 6
PRK 
(n = 25)
TF LASIK  
(n = 25)
P  
valuea
PRK 
(n = 25)
TF LASIK  
(n = 25)
P  
valuea
PRK 
(n = 25)
TF LASIK  
(n = 25)
P  
valuea
Efficacy (UDVA) 0.009 0.699 0.718
20/15 or better 1 (4) 7 (29) 11 (44) 12 (48) 9 (38) 13 (54)
20/20 or better 11 (44) 21 (84) 24 (96) 23 (92) 24 (96) 23 (92)
20/25 or better 19 (76) 24 (98) 25 (100) 23 (92) 25 (100) 24 (96)
20/30 or better 23 (92) 24 (98) 25 (100) 25 (100)
20/40 or better 24 (96) 25 (100)
20/50 or better 25 (100)
Predictability 0.189 0.630 0.242
±0.50 D of emmetropia 19 (76) 23 (92) 24 (96) 23 (92) 23 (92) 22 (88)
±1.00 D of emmetropia 5 (20) 2 (8) 1 (4) 2 (8) 2 (8) 3 (12)
±1.50 D of emmetropia 1 (4)
Safety (CDVA) 0.011 0.578 0.462
Loss of 2 lines 2 (8) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Loss of 1 line 4 (16) 2 (9) 2 (8) 1 (4) 0 (0) 0 (0)
no loss of lines 16 (64) 14 (56) 11 (44) 13 (52) 9 (36) 11 (44)
gain of 1 line 3 (12) 9 (39) 11 (42) 10 (40) 15 (60) 13 (52)
gain of 2 lines or more 0 (0) 0 (0) 1 (4) 1 (4) 1 (4) 1 (4)
Notes: Values represented as mean ± standard deviation (range); aindependent samples t-test.
Abbreviations: UDVA, uncorrected distance visual acuity; CDVA, corrected distance visual acuity.
acuity, and HOAs were treated as continuous variables and 
analyzed for significance by independent t-tests. In all tests, 
P values ,0.05 were considered statistically significant. 
Data analysis was done using Microsoft Excel (Microsoft 
Corp, Redmond, WA).
Results
Mean preoperative measurements of UDVA, CDVA, sphere, 
and cylinder are shown in Table 1. 25 of 26 patients (50 eyes) 
completed the study at postoperative 6 months. One eye in the 
thin-flap LASIK group required PRK retreatment following a 
flap tear and both eyes from this patient were therefore removed 
from analysis of visual acuity, contrast sensitivity, and HOAs 
as the retreatment prevented the ability to distinguish results 
between the 2 surgical methods. The eyes from this patient 
were still included in the analysis of complications.
Visual acuity
Table 2 shows visual acuity outcomes at 1, 3, and 6 months 
postoperatively. Statistically significant differences were 
found between PRK and thin-flap LASIK in UDVA at 
1 month postoperatively, with thin-flap LASIK eyes show-
ing more improvement in UDVA. Visual acuities were not 
statistically different between the groups at 3 or 6 months.
stability, efficacy, and predictability
Table 3 shows stability, efficacy, and predictability outcomes 
postoperatively at 1, 3, and 6 months. CDVA was statistically 
different between groups at 1 month, with 24% of the PRK 
group losing a line or more from preoperative values, while 
9% of eyes in the thin-flap LASIK group lost only 1 line at 
1 month. No eyes in the thin-flap LASIK group lost more 
than 1 line. Also, 39% of eyes in the thin-flap group gained 
a line by 1 month compared with only 12% of eyes in the 
PRK group. At 6 months 64% and 56% of eyes had gained 
a line or more of CDVA in the PRK and thin-flap LASIK 
groups, respectively (P = 0.462).
Contrast sensitivity
Contrast sensitivity measurements at 3, 6, 12, and 18 cycles 
per degree (cpd) in each group are shown in Figure 1. There 
were no differences between groups at any cpd at any time 
in the study (P $ 0.156). The thin-flap LASIK group showed 
no change in contrast sensitivity postoperatively (P . 0.131), 
while patients in the PRK group had a slight decrease in con-
trast sensitivity at 1 month seen at 3 and 12 cpd (P = 0.004) and 
(P = 0.025), respectively. At 6 months contrast sensitivity in 
the PRK group was still significantly decreased from baseline 
at 3 cpd (P = 0.013), although it did not reach a statistically 
significant difference at 3 months (P = 0.101).
Complications
Types of complications differed between the 2 groups. In the PRK 
group, 2 cases of epithelial defects occurred by 1 week, but had 
completely resolved by 6 months. Three eyes in the PRK group 
had mild haze appearing as early as 1 week   postoperatively. Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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Haze remained in only 1 eye at 6 months, but was classified as 
minimal and had no effect on UDVA or CDVA.
Nine eyes (35%) in the thin-flap LASIK group expe-
rienced complications. In the thin-flap LASIK group, flap 
debris (1 eye), diffuse lamellar keratitis (DLK, 1 eye), and 
an epithelial cyst at the edge of 1 flap were observed, with 
no loss of UDVA or CDVA, and all resolved by 6 months. 
Microstriae were observed in 6 eyes, one of which was the 
eye described above with flap debris and the other was the 
eye with DLK, with no associated loss of UDVA or CDVA, 
with epithelial proliferation noted as filling the microstria and 
making them less apparent. Two eyes in the thin-flap LASIK 
group experienced flap tears intraoperatively – one resulting 
in mild flap edge scarring by 6 months that had no significant 
effect on visual function, and the other case affecting vision 
at 1 month postoperatively which was retreated with PRK 
at 3 months. As a result of the retreatment with the counter 
surgical technique, the ability to accurately compare visual 
acuity, contrast sensitivity, and HOAs between the 2 surgical 
methods was limited and both eyes from this patient were 
removed from analysis of these measures, but were still 
included in the analysis of complications.
Higher-order aberrations
At postoperative 1, 3, and 6 months, 24 (96%), 25 (100%), 
and 24 (96%) eyes, respectively, in each group completed 
CustomVue WaveScan analysis. Total root-mean square 
(RMS) HOAs, coma, trefoil, and spherical aberrations are 
compared in Figure 2. There were no significant differ-
ences between groups in any HOAs throughout the study 
(P $ 0.101), with all P values at 6 months $0.63. In both 
groups, total HOAs (P , 0.008), spherical (P , 0.002), 
and coma (P = 0.008 at 3 months; P = 0.024 at 6 months) 
aberrations were significantly increased compared with pre-
operative conditions. Trefoil showed no significant change 
throughout the study in either group (P = 0.298).Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Discussion/conclusion
The present study confirms that PRK and thin-flap LASIK 
are effective surgeries for the correction of low to moderate 
myopia. Although thin-flap LASIK showed superior visual 
results in the early postoperative period there was no statisti-
cally significant difference in outcomes of UDVA, CDVA, 
contrast sensitivity, or total RMS HOAs between PRK and 
thin-flap LASIK by 6 months. In a similar study comparing 
PRK and thin-flap LASIK, Slade et al also found that UDVA 
results were better in the thin-flap group early on and equal-
ized by 6 months.16 Our study showed a similar trend, with 
no significant differences in any of the primary outcomes 
at 6 months, and with no difference in UDVA at 3 months. 
Visual regression in our study was similar to outcomes in 
Slade’s study in which 42% of the PRK group lost a line or 
more of CDVA and 22% of the thin-flap LASIK group lost 
1 line at 1 month postoperatively.
Despite the use of custom ablation, postoperative increases 
in total HOAs, sphere, and coma were noted in our study, as 
also seen by Slade et al, although they noted that the increase 
in sphere and coma aberrations was significantly higher in 
the PRK group at 1 and 3 months postoperatively. As found 
in previous studies, there was no significant change found 
in trefoil at any time postoperatively.17,18 Our study showed 
no difference in induction of HOAs between groups at any 
time. Although increases in HOAs after refractive surgery 
have been correlated with decreases in contrast sensitivity 
in other studies, we demonstrate that increases in total RMS, 
sphere, and coma were seen postoperatively in both groups 
without a reliable decrease in contrast sensitivity.19,20 Slade’s 
group found that contrast sensitivity was better in the thin-
flap group at all postoperative points in the study, which may 
have been related to their finding of lower induction of sphere 
and coma aberrations in the thin-flap group compared with 
the PRK group. The authors recognize that the Slade study 
had a larger population size (n = 50 per group) and would 
have increased power to detect significant differences. Our 
study would have had increased power of analysis with a 
similar study group size, but results from analysis of HOAs 
would not likely change as P values for all HOAs at 6 months 
were $0.63. It would be difficult to make any such correla-
tion between contrast sensitivity and HOAs from the results 
of this study.
A loss of CDVA has been associated with the develop-
ment of corneal haze in other studies, but as mentioned 
above none of the patients with visual regression devel-
oped haze.21–23 Findings in other studies showing that the 
biomechanics of eyes that have received thin-flap LASIK 
treatment are indistinguishable from those of PRK have led 
to suggestions that thin-flap LASIK is the best approach to 
LASIK.16 Although the present study did not find any statisti-
cally significant differences between thin-flap LASIK and 
PRK in terms of visual quality at 6 months, complications 
dealing with flap integrity in the thin-flap LASIK group were 
present which are not complications found in PRK. Although 
PRK remains a viable option for those unable to undergo 
LASIK, the use of thinner flaps may eliminate some of the 
complications seen with traditional LASIK. Larger studies 
are needed to better compare the complication rates of both 
methods and to determine how effective thin-flap LASIK 
will be in achieving the benefits of PRK and LASIK while 
avoiding the risks associated with each method.
While thinner LASIK flaps attempt to preserve the 
biomechanical stability of the corneal stroma, at the same 
time, the flap itself becomes less stable, as was noted with 
the 2 flap tears and other complications occurring in the 
thin-flap LASIK group in this study. A study by Espandar 
and Meyer24 showed that most complications in flaps cre-
ated by IntraLase femtosecond laser occurred at the hinge, 
which is where the 2 flap tears that occurred in this study. 
A thinner flap hinge would be biomechanically less stable 
and would increase the likelihood of intraoperative flap tear 
occurrence as well. Six of the 9 eyes with complications in 
the thin-flap LASIK group had microstriae, which are caused 
by the flattening of a weak corneal flap unable to maintain 
its curvature over the small area of stroma removed during 
ablation. The biomechanics of the flap and hinge, however, 
cannot be evaluated by the design of this study as analysis 
was done based on intended flap thickness, which has been 
shown to vary with the IntraLase FS60 femtosecond laser.25 
The study could have been strengthened had intraoperative 
pachymetry or OCT been performed.
Creating a flap with increased integrity would help pre-
vent microstriae from forming and would also provide for 
a stronger hinge that would be less susceptible to flap tear. 
Possible ways to optimize flap integrity include modification 
of hinge and side-cut angle creation, as well as improved 
planarity and microdisruption of flap edges. This will allow 
improved adhesion of the flap to the underlying stroma. 
Continued improvements in laser technology may allow for 
safer creation of thinner flaps, helping to provide evidence 
for superior outcomes in thin-flap LASIK, permitting the 
biomechanical stability of PRK with the visual recovery of 
LASIK. Custom flap formation that minimizes weak areas 
susceptible to tearing will be helpful in achieving this difficult 
balance between corneal and flap integrity.Clinical Ophthalmology
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